295 related articles for article (PubMed ID: 16221737)
1. Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis.
Bergheim I; Guo L; Davis MA; Duveau I; Arteel GE
J Pharmacol Exp Ther; 2006 Feb; 316(2):592-600. PubMed ID: 16221737
[TBL] [Abstract][Full Text] [Related]
2. PAI-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA.
Wang H; Zhang Y; Heuckeroth RO
FEBS Lett; 2007 Jun; 581(16):3098-104. PubMed ID: 17561000
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice.
Wang H; Vohra BP; Zhang Y; Heuckeroth RO
Hepatology; 2005 Nov; 42(5):1099-108. PubMed ID: 16250054
[TBL] [Abstract][Full Text] [Related]
4. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
5. PAI-1 plays a protective role in CCl4-induced hepatic fibrosis in mice: role of hepatocyte division.
von Montfort C; Beier JI; Kaiser JP; Guo L; Joshi-Barve S; Pritchard MT; States JC; Arteel GE
Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G657-66. PubMed ID: 20203062
[TBL] [Abstract][Full Text] [Related]
6. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosis.
Beier JI; Kaiser JP; Guo L; Martínez-Maldonado M; Arteel GE
Arch Biochem Biophys; 2011 Jun; 510(1):19-26. PubMed ID: 21501583
[TBL] [Abstract][Full Text] [Related]
8. Tissue-type plasminogen activator deficiency exacerbates cholestatic liver injury in mice.
Wang H; Zhang Y; Heuckeroth RO
Hepatology; 2007 Jun; 45(6):1527-37. PubMed ID: 17538930
[TBL] [Abstract][Full Text] [Related]
9. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
[TBL] [Abstract][Full Text] [Related]
10. A contradictory role of A1 adenosine receptor in carbon tetrachloride- and bile duct ligation-induced liver fibrosis in mice.
Yang P; Han Z; Chen P; Zhu L; Wang S; Hua Z; Zhang J
J Pharmacol Exp Ther; 2010 Mar; 332(3):747-54. PubMed ID: 20007753
[TBL] [Abstract][Full Text] [Related]
11. Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats.
Zhong Z; Froh M; Lehnert M; Schoonhoven R; Yang L; Lind H; Lemasters JJ; Thurman RG
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1004-13. PubMed ID: 12791596
[TBL] [Abstract][Full Text] [Related]
12. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
[TBL] [Abstract][Full Text] [Related]
13. Deletion of clock gene Per2 exacerbates cholestatic liver injury and fibrosis in mice.
Chen P; Kakan X; Wang S; Dong W; Jia A; Cai C; Zhang J
Exp Toxicol Pathol; 2013 May; 65(4):427-32. PubMed ID: 22261359
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats.
Zhao S; Li N; Zhen Y; Ge M; Li Y; Yu B; He H; Shao RG
Food Chem Toxicol; 2015 Dec; 86():202-7. PubMed ID: 26498411
[TBL] [Abstract][Full Text] [Related]
15. Cholestasis-induced fibrosis is reduced by interferon alpha-2a and is associated with elevated liver metalloprotease activity.
Bueno MR; Daneri A; Armendáriz-Borunda J
J Hepatol; 2000 Dec; 33(6):915-25. PubMed ID: 11131453
[TBL] [Abstract][Full Text] [Related]
16. Early growth response factor-1 is critical for cholestatic liver injury.
Kim ND; Moon JO; Slitt AL; Copple BL
Toxicol Sci; 2006 Apr; 90(2):586-95. PubMed ID: 16423862
[TBL] [Abstract][Full Text] [Related]
17. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
18. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: Potential role for silent information regulator 1 (SIRT1).
Abd El Motteleb DM; Ibrahim IAAE; Elshazly SM
Toxicol Appl Pharmacol; 2017 Nov; 335():64-71. PubMed ID: 28974454
[TBL] [Abstract][Full Text] [Related]
20. Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-beta signaling pathway.
Min AK; Kim MK; Seo HY; Kim HS; Jang BK; Hwang JS; Choi HS; Lee KU; Park KG; Lee IK
Biochem Biophys Res Commun; 2010 Mar; 393(3):536-41. PubMed ID: 20153726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
